Kimberly J. Popovits's Insider Trades & SAST Disclosures
Kimberly J. Popovits's most recent trade in Exact Sciences Corp. was a trade of 6,387 Common Stock done . Disclosure was reported to the exchange on Jan. 2, 2025.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Kimberly J. Popovits.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Exact Sciences Corp. | Kimberly J. Popovits | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jan 2025 | 6,387 | 6,387 (0%) | 0% | 0 | Common Stock | |
| 10x Genomics Inc - Ordinar... | Kimberly J. Popovits | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Jun 2024 | 8,649 | 13,259 (0%) | 0% | 0 | Class A Common Stock | |
| Kiniksa Pharmaceuticals Lt... | Kimberly J. Popovits | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jun 2024 | 19,040 | 19,040 | - | - | Share Option | |
| Kiniksa Pharmaceuticals Lt... | Kimberly J. Popovits | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Jun 2024 | 4,373 | 9,373 (0%) | 0% | - | Class A Common Share | |
| Kiniksa Pharmaceuticals Lt... | Kimberly J. Popovits | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Jun 2024 | 4,373 | 0 | - | - | Restricted Share Units | |
| Kiniksa Pharmaceuticals Lt... | Kimberly J. Popovits | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jun 2024 | 3,173 | 3,173 | - | - | Restricted Share Units | |
| Kiniksa Pharmaceuticals Lt... | Kimberly J. Popovits | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 29 Jun 2023 | 5,000 | 0 | - | - | Restricted Share Units | |
| Kiniksa Pharmaceuticals Lt... | Kimberly J. Popovits | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 29 Jun 2023 | 5,000 | 5,000 (0%) | 0% | - | Class A Common Share | |
| 10x Genomics Inc - Ordinar... | Kimberly J. Popovits | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jun 2023 | 4,661 | 4,661 | - | - | Stock Option (right to buy) | |
| 10x Genomics Inc - Ordinar... | Kimberly J. Popovits | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jun 2023 | 1,865 | 4,610 (0%) | 0% | 0 | Class A Common Stock | |
| Talis Biomedical Corp | Kimberly J. Popovits | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Jun 2023 | 95,000 | 95,000 | - | - | Stock option (right to buy) | |
| Kiniksa Pharmaceuticals Lt... | Kimberly J. Popovits | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jun 2023 | 26,236 | 26,236 | - | - | Share Option | |
| Kiniksa Pharmaceuticals Lt... | Kimberly J. Popovits | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jun 2023 | 4,373 | 4,373 | - | - | Restricted Share Units | |
| Kiniksa Pharmaceuticals Lt... | Kimberly J. Popovits | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Jun 2022 | 30,000 | 30,000 | - | - | Share Option | |
| Kiniksa Pharmaceuticals Lt... | Kimberly J. Popovits | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Jun 2022 | 5,000 | 5,000 | - | - | Restricted Share Units | |
| 10x Genomics Inc - Ordinar... | Kimberly J. Popovits | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jun 2022 | 5,300 | 5,300 | - | - | Stock Option (right to buy) | |
| 10x Genomics Inc - Ordinar... | Kimberly J. Popovits | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jun 2022 | 2,120 | 2,745 (0%) | 0% | 0 | Class A Common Stock | |
| Talis Biomedical Corp | Kimberly J. Popovits | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jun 2022 | 95,000 | 95,000 | - | - | Stock Option (right to buy) | |
| Talis Biomedical Corp | Kimberly J. Popovits | Interim CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Aug 2021 | 550,000 | 550,000 | - | - | Stock Option (right to buy) | |
| Kiniksa Pharmaceuticals Lt... | Kimberly J. Popovits | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Jun 2021 | 33,237 | 33,237 | - | - | Share Option | |
| 10x Genomics Inc - Ordinar... | Kimberly J. Popovits | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Jun 2021 | 1,563 | 1,563 | - | - | Stock Option (right to buy) | |
| 10x Genomics Inc - Ordinar... | Kimberly J. Popovits | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Jun 2021 | 625 | 625 (0%) | 0% | 0 | Class A Common Stock | |
| Talis Biomedical Corp | Kimberly J. Popovits | Director | 17 Feb 2021 | 300,000 | 0 | - | - | Series E-1 Preferred Stock | ||
| Talis Biomedical Corp | Kimberly J. Popovits | Director | 17 Feb 2021 | 209,790 | 209,790 | - | - | Common Stock | ||
| Talis Biomedical Corp | Kimberly J. Popovits | Director | 17 Feb 2021 | 131,642 | 0 | - | - | Series E-1 Preferred Stock | ||
| Talis Biomedical Corp | Kimberly J. Popovits | Director | 17 Feb 2021 | 128,655 | 0 | - | - | Series F-1 Preferred Stock | ||
| Talis Biomedical Corp | Kimberly J. Popovits | Director | 17 Feb 2021 | 92,057 | 92,057 | - | - | Common Stock | ||
| Talis Biomedical Corp | Kimberly J. Popovits | Director | 17 Feb 2021 | 89,968 | 182,025 | - | - | Common Stock | ||
| Talis Biomedical Corp | Kimberly J. Popovits | Director | 17 Feb 2021 | 31,519 | 0 | - | - | Series C-1 Preferred Stock | ||
| Talis Biomedical Corp | Kimberly J. Popovits | Director | 17 Feb 2021 | 22,041 | 25,776 | - | - | Common Stock | ||
| Talis Biomedical Corp | Kimberly J. Popovits | Director | Purchase of securities on an exchange or from another person at price $ 16.00 per share. | 17 Feb 2021 | 5,300 | 215,090 | - | 16 | 84,800 | Common Stock |
| Kiniksa Pharmaceuticals Lt... | Kimberly J. Popovits | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Jun 2020 | 18,760 | 18,760 | - | - | Share Option | |
| 10x Genomics Inc - Ordinar... | Kimberly J. Popovits | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jun 2020 | 4,432 | 4,432 | - | - | Stock Option (right to buy) | |
| 10x Genomics Inc - Ordinar... | Kimberly J. Popovits | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Mar 2020 | 10,330 | 10,330 | - | - | Stock Option (right to buy) |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges